Young plasma treatment decreased the level of tau phosphorylation at threonine 231 and showed a trend to reduce tau phosphorylation at serine 396 and 404 with PHF1 antibody (Fig. 5 c and d).
← all excerpts
Young blood plasma reduces Alzheimer's disease-like brain pathologies and ameliorates cognitive impairment in 3×Tg-AD mice.
1
—
—